VCM
FPRX

Versant Capital Management’s Five Prime Therapeutics, Inc. FPRX Stock Holding History

Versant Capital Management’s Portfolio FPRX Stock Details FPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-50
Closed – – 1692
2019
Q3 		$0 Buy
+50
New – ﹤0.01% 1697